Sr One Capital Management as of March 31, 2025
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 12 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 39.5 | $154M | 2.3M | 65.60 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 13.0 | $51M | 4.0M | 12.58 | |
| Mineralys Therapeutics Common Stock (MLYS) | 12.8 | $50M | 3.1M | 15.88 | |
| Zenas BioPharma Common Stock (ZBIO) | 10.0 | $39M | 4.9M | 7.90 | |
| CRISPR Therapeutics Common Shares (CRSP) | 9.2 | $36M | 1.0M | 34.03 | |
| Design Therapeutics Common Stock (DSGN) | 6.5 | $25M | 6.5M | 3.86 | |
| Alumis Common Stock (ALMS) | 3.1 | $12M | 2.0M | 6.14 | |
| Oculis Holding Ordinary Shares (OCS) | 1.6 | $6.1M | 323k | 19.03 | |
| Nkarta Common Stock (NKTX) | 1.6 | $6.1M | 3.3M | 1.84 | |
| Oruka Therapeutics Common Stock (ORKA) | 1.1 | $4.4M | 430k | 10.26 | |
| KALA Bio Common Stock (KALA) | 0.9 | $3.4M | 599k | 5.73 | |
| enGene Holdings Common Shares (ENGN) | 0.9 | $3.3M | 748k | 4.48 |
